An open study of olanzapine and fluoxetine for psychotic major depressive disorder: Interim analyses

Journal of Clinical Psychiatry

Volumn 63, Issue 12, 2002, Pages 1164-1170

  Matthews, John D ^a   Bottonari, Kathryn A ^a   Polania, Laura M ^a   Mischoulon, David ^a   Dording, Christina M ^a   Irvin, Robert ^a   Fava, Maurizio ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DIAZEPAM; FLUOXETINE; GABAPENTIN; HALOPERIDOL; MIRTAZAPINE; NEFAZODONE; NEUROLEPTIC AGENT; NORTRIPTYLINE; OLANZAPINE; PERPHENAZINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ANOREXIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DELUSION; DRUG DOSE REGIMEN; DRUG EFFICACY; FATIGUE; FEMALE; GASTROINTESTINAL DISEASE; HALLUCINATION; HAMILTON SCALE; HEADACHE; HUMAN; INCREASED APPETITE; MAJOR DEPRESSION; MALE; MELANCHOLIA; PRIORITY JOURNAL; SEDATION; TREATMENT OUTCOME; VERTIGO; WEIGHT GAIN; XEROSTOMIA;

EID: 0036940237     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v63n1212     Document Type: Article

References (54)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
2. Coryell W, Zimmerman M. Demographic, historical, and symptomatic features of the nonmanic psychoses. J Nerv Ment Dis 1986;174:585-592
3. Jorgensen P. Manic-depressive patients with delusions. Acta Psychiatr Scand 1985;72:364-368
4. Agren H, Terenius L. Hallucinations in patients with major depression: interactions between CSF monoaminergic and endorphinergic indices. J Affect Disord 1985;9:25-34
5. Frangos E, Athanassenas G, Tsitourides P, et al. Psychotic depressive disorder: a separate entity? J Affect Disord 1983;5:259-265
6. Charney DS, Nelson JC. Delusional and nondelusional unipolar depression: further evidence for distinct subtypes. Am J Psychiatry 1981;138:328-333
7. Coryell W, Pfohl B, Zimmerman M. The clinical and neuroendocrine features of psychotic depression. J Nerv Ment Dis 1984;172:521-528
8. Dubovsky SL, Thomas M. Psychotic depression: advances in conceptualization and treatment. Hosp Community Psychiatry 1992;43:1189-1198
9. Frances A, Brown RP, Kocsis JH, et al. Psychotic depression: a separate entity? Am J Psychiatry 1981;138:831-833
10. Lykouras E, Christodoulou GN, Malliaras D. Type and content of delusions in unipolar psychotic depression. J Affect Disord 1985;9:249-252
11. Nelson WH, Khan A, Orr WW. Delusional depression: phenomenology, neuroendocrine function, and tricyclic antidepressant response. J Affect Disord 1985;9:297-306
12. Glassman AH, Roose SP. Delusional depression: a distinct clinical entity? Arch Gen Psychiatry 1981;38:424-427
13. Avery D, Lubano A. Depresssion treated with imipramine and ECT: the DeCarolis study reconsidered. Am J Psychiatry 1979;136:559-562
14. Goshen CE. Documentary History of Psychiatry. New York, NY: Philosophical Library; 1967
15. Glassman AH, Kantor SJ, Shostak M. Depression, delusions, and drug response. Am J Psychiatry 1975;132:716-719
16. Chan CH, Janicak PG, Davis JM. et al. Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants. J Clin Psychiatry 1987;48:197-200
17. Nelson JC, Bowers MB. Delusional unipolar depression: description and drug response. Arch Gen Psychiatry 1978;35:1321-1328
18. Minter RE, Mandel MR. The treatment of psychotic major depressive disorder with drugs and electroconvulsive therapy. J Nerv Ment Dis 1979;167:726-733
19. Minter RE, Mandel MR. A prospective study of the treatment of psychotic depression. Am J Psychiatry 1979;136:1470-1472
20. Kaskey GB, Nasr S, Meltzer HY. Drug treatment in delusional depression. Psychiatry Res 1980;1:267-277
21. Spiker DG, Weiss JC, Dealy RS, et al. The pharmacological treatment of delusional depression. Am J Psychiatry 1985;142:430-436
22. Rothschild AJ, Samson JA. Bessette MP, et al. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression. J Clin Psychiatry 1993;54:338-342
23. Wolfersdorf M, Barg T, Konig F, et al. Paroxetine as an antidepressant in combined antidepressant-neuroleptic therapy in delusional depression: observation of clinical use. Pharmacopsychiatry 1995;28:56-60
24. Gatti F, Bellini L, Gasperini M, et al. Fluvoxamine alone in the treatment of delusional depression. Am J Psychiatry 1996;153:414-416
25. Zanardi R, Franchini L, Gasperini M, et al. Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression. Am J Psychiatry 1996;153:1631-1633
26. Zanardi R, Franchini L, Gasperini M, et al. Long-term treatment of psychotic (delusional) depression with fluvoxamine: an open pilot study. Int Clin Psychopharmacol 1997;12:195-197
27. Dassa D, Kaladjian A, Azorin JM, et al. Clozapine in the treatment of psychotic refractory depression. Br J Psychiatry 1993;163:822-824
28. Hillert A, Maier W, Wetzel H, et al. Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome: a functional approach. Pharmacopsychiatry 1992;25:213-217
29. Zarate CA, Tohen M, Baldessarini RJ. Clozapine in severe mood disorders. J Clin Psychiatry 1995;56:411-417
30. Ranjan R, Meltzer HY. Acute and long-term effectiveness of clozapine in treatment-resistant psychotic depression. Biol Psychiatry 1996;40:253-258
31. Lane HY, Chang WH. Risperidone monotherapy for psychotic depression unresponsive to other treatments [letter]. J Clin Psychiatry 1998;59:624
32. Muller-Siecheneder F, Muller MJ, Hillert A, et al. Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome. J Clin Psychopharmacol 1998;18:111-120
33. Kaiya H, Takeda N. Sulpiride in the treatment of delusional depression [letter]. J Clin Psychopharmacol 1990;10:147
34. Rothschild AJ, Bates KS, Boehringer KL, et al. Olanzapine response in psychotic depression. J Clin Psychiatry 1999;60:116-118
35. Adli M, Rossius W, Bauer M. Olanzapine in the treatment of depressive disorders with psychotic symptoms. Nervenarzt 1999;70:68-71
36. Tollefson GD, Sanger TM, Andersen SW. The use of an olanzapine:fluoxetine combination in the treatment of major depression with psychotic features: results form a large, prospective, double-blind trial. Presented at the 40th annual meeting of the American College of Neuropsychopharmacology; Dec 9-13, 2001; Waikoloa, Hawaii
37. Mathew S, Shelton RC, Paul S, et al. Olanzapine-fluoxetine combination in treatment-resistant depression. Presented at the 40th annual meeting of the American College of Neuropsychopharmacology; Dec 9-13, 2001; Waikoloa, Hawaii
38. Spitzer RL, Williams JBW, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders User's Guide and Interview (SCID-I, Research Version). New York, NY: Biometric Research, New York State Psychiatric Institute; 1995
39. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
40. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:218-222
41. Tsuang D, Coryell W. An 8-year follow-up of patients with DSM-III-R psychotic depression, schizoaffective disorder, and schizophrenia. Am J Psychiatry 1993;150:1182-1188
42. Coryell W, Leon A, Winokur G, et al. Importance of psychotic features to long-term course in major depressive disorder. Am J Psychiatry 1996;153:483-489
43. Beasley CM, Sanger T, Satterlee W, et al. Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial. Psychopharmacology (Berl) 1996;124:159-167
44. Tohen M, Sanger T, McElroy S, et al, for the Olanzapine HGEH Study Group. Olanzapine versus placebo in the treatment of acute mania. Am J Psychiatry 1999;156:702-709
45. Zyprexa (olanzapine). Physicians' Desk Reference. Montvale, NJ: Medical Economics; 2001:1788-1793
46. Schatzberg A, Rothschild AJ. Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV? Am J Psychiatry 1992;149:733-745
47. Thakur M, Hays J, Ranga K, et al. Clinical, demographic and social characteristics of psychotic depression. Psychiatry Res 1999;86:99-106
48. Nelson JC, Conwell Y, Kim K, et al. Age at onset in late-life delusional depression. Am J Psychiatry 1989;146:785-786
49. Brodaty H, Luscombe G, Parker G, et al. Increased rate of psychosis and psychomotor change in depression with age. Psychol Med 1997;27:1205-1213
50. Aronson TA, Shukla S, Gujavarty K, et al. Relapse in delusional depression: a retrospective study of the course and treatment. Compr Psychiatry 1988;29:12-21
51. Solan WJ, Khan A, Avery DH, et al. Psychotic and nonpsychotic depression: comparison of response to ECT. J Clin Psychiatry 1988;49:97-99
52. Sobin C, Prudic J, Devanand DP, et al. Who responds to electroconvulsive therapy? a comparison of effective and ineffective forms of treatment. Br J Psychiatry 1996;169:322-328
53. Petrides G, Fink M, Husain MM, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT 2001;4:244-253
54. Anton RF, Burch EA. Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression. Am J Psychiatry 1990; 147:1203-1208